XML 27 R16.htm IDEA: XBRL DOCUMENT v3.25.3
LOSS PER SHARE APPLICABLE TO COMMON STOCKHOLDERS
 9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
LOSS PER SHARE APPLICABLE TO COMMON STOCKHOLDERS

NOTE 10 - LOSS PER SHARE APPLICABLE TO COMMON STOCKHOLDERS

 

Basic net loss per common share (“Basic EPS”) is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. All outstanding stock options and warrants for the three and nine months ended September 30, 2025, and 2024 have been excluded from the calculation of the diluted net loss per share because all such securities are anti-dilutive for all periods presented, except for prefunded warrants.

 

The following table sets forth the computation of the net loss per share for the period presented:

 

   Three Months Ended September 30,   Three Months Ended September 30,   Nine Months Ended September 30,   Nine Months Ended September 30, 
   2025   2024   2025   2024 
Numerator:                
Net income (loss)  $510   $(998)  $(5,333)  $(2,274)
Dividend on Series X Convertible Preferred   (758)   -    (1,102)   - 
Dividend on Series H Convertible Preferred   (223)   -    (223)   - 
Deemed dividend for down round on Series H (See note 6)   (399)   -    (399)   - 
Deemed contribution on repurchase of Preferred Series X   90    -    90    - 
Deemed contribution (See note 6)   -    -    3,815    - 
Net loss available to common stockholders  $(780)  $(998)  $(3,152)  $(2,274)

 

The following table summarizes the Company’s securities, in common stock equivalents, which have been excluded from the calculation of dilutive loss per share as their effect would be anti-dilutive:

 

   September 30, 2025   September 30, 2024 
Stock options – employee and non-employee  $4,411   $202,650 
Warrants   1,071,463    7,623,229 
Total  $1,075,874   $7,828,879 

 

The diluted loss per share equals basic loss per share in the three and nine months ended September 30, 2025, and 2024 because the Company had a net loss and the impact of the assumed exercise of stock options and the vesting of restricted stock would have been anti-dilutive.